DOW JONES21,413.44+469.93 2.24%
S&P 5002,526.90+56.40 2.28%
NASDAQ7,487.31+126.73 1.72%

Cantor Fitzgerald Maintains Neutral on Eagle Pharmaceuticals, Lowers Price Target to $46

Cantor Fitzgerald analyst Brandon Folkes maintains Eagle Pharmaceuticals (NASDAQ:EGRX) with a Neutral and lowers the price target from $58 to $46.

Benzinga · 03/02/2020 17:12

Cantor Fitzgerald analyst Brandon Folkes maintains Eagle Pharmaceuticals (NASDAQ:EGRX) with a Neutral and lowers the price target from $58 to $46.